Skip to main content
Retour
TMO logo

Thermo Fisher Scientific Inc.

Qualité des données : 100%
TMO
NYSE Healthcare Medical - Diagnostics & Research
478,12 €
▲ 3,73 € (0,79%)
Cap. Boursière : 177,61B
Fourchette du Jour
475,65 € 487,93 €
Fourchette 52 Semaines
385,46 € 643,99 €
Volume
1 444 446
Moyenne 50J / 200J
545,40 € / 514,90 €
Clôture Précédente
474,39 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (626 pairs)

Métrique Action Médiane du Secteur
P/E 26,4 0,4
P/B 3,3 2,9
ROE % 13,1 3,7
Net Margin % 15,1 3,8
Rev Growth 5Y % 3,3 10,0
D/E 0,8 0,2

Insider Trading Activity

20 transactions
Date Insider Type Shares Price Value
Feb 28, 2026
Lowery Frederick M.
Executive Vice President
other 897 521,11 € 467 436 €
Feb 25, 2026
Lowery Frederick M.
Executive Vice President
grant 1 638
Dec 4, 2025
Lagarde Michel
Executive Vice President & COO
other 81 366 105,17 €
Dec 4, 2025
Lagarde Michel
Executive Vice President & COO
sell 22 046 563,56 € 12 424 244 €
Dec 3, 2025
Lagarde Michel
Executive Vice President & COO
other 136 000 105,17 €
Dec 3, 2025
Lagarde Michel
Executive Vice President & COO
sell 32 000 583,33 € 18 668 526 €
Dec 2, 2025
Lagarde Michel
Executive Vice President & COO
other 72 000 105,17 €
Dec 2, 2025
Lagarde Michel
Executive Vice President & COO
sell 30 000 581,92 € 17 457 600 €
Dec 2, 2025
Lowery Frederick M.
Executive Vice President
other 13 824 253,99 €
Dec 2, 2025
Lowery Frederick M.
Executive Vice President
sell 6 912 581,94 € 4 022 369 €
Dec 1, 2025
Lowery Frederick M.
Executive Vice President
other 13 826 253,99 €
Dec 1, 2025
Lowery Frederick M.
Executive Vice President
sell 6 913 597,68 € 4 131 762 €
Nov 13, 2025
Lagarde Michel
Executive Vice President & COO
other 9 276 253,99 €
Nov 13, 2025
Lagarde Michel
Executive Vice President & COO
sell 4 638 594,42 € 2 756 920 €
Aug 28, 2025
Lowery Frederick M.
Executive Vice President
other 668 489,74 € 327 146 €
Aug 22, 2025
CASPER MARC N
Chairman & CEO
other 20 000 253,99 €
Aug 22, 2025
CASPER MARC N
Chairman & CEO
sell 10 000 500,40 € 5 009 586 €
Aug 20, 2025
CASPER MARC N
Chairman & CEO
other 590 253,99 €
Aug 20, 2025
CASPER MARC N
Chairman & CEO
sell 295 500,00 € 147 512 €
Aug 19, 2025
CASPER MARC N
Chairman & CEO
other 402 253,99 €

Points Clés

Revenue grew 3,25% annually over 5 years — modest growth
ROE of 13,08% — decent returns on equity
Net margin of 15,12% shows strong profitability
Generating 6,29B in free cash flow
Cash machine — converts 93,41% of earnings into free cash flow
Capital efficient — spends only 3,42% of revenue on capex

Croissance

Revenue Growth (5Y)
3,25%
Revenue (1Y)3,91%
Earnings (1Y)6,35%
FCF Growth (3Y)-4,69%

Qualité

Return on Equity
13,08%
ROIC6,45%
Net Margin15,12%
Op. Margin18,20%

Sécurité

Debt / Equity
0,76
Current Ratio1,89
Interest Coverage5,71

Valorisation

P/E Ratio
26,36
P/B Ratio3,33
EV/EBITDA25,73
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 3,91% Revenue Growth (3Y) 1,96%
Earnings Growth (1Y) 6,35% Earnings Growth (3Y) 6,01%
Revenue Growth (5Y) 3,25% Earnings Growth (5Y) -3,36%
Profitability
Revenue (TTM) 44,56B Net Income (TTM) 6,74B
ROE 13,08% ROA 6,11%
Gross Margin 37,66% Operating Margin 18,20%
Net Margin 15,12% Free Cash Flow (TTM) 6,29B
ROIC 6,45% FCF Growth (3Y) -4,69%
Safety
Debt / Equity 0,76 Current Ratio 1,89
Interest Coverage 5,71 Dividend Yield 0,00%
Valuation
P/E Ratio 26,36 P/B Ratio 3,33
P/S Ratio 3,99 PEG Ratio 4,51
EV/EBITDA 25,73 Dividend Yield 0,00%
Market Cap 177,61B Enterprise Value 208,61B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 44,56B 42,88B 42,86B 44,92B 39,21B
Net Income 6,74B 6,34B 6,00B 6,95B 7,73B
EPS (Diluted) 17,74 16,53 15,45 17,64 19,46
Gross Profit 16,78B 17,73B 17,19B 19,01B 19,63B
Operating Income 8,11B 7,66B 7,45B 8,53B 10,32B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 110,34B 97,32B 98,73B 97,15B 95,12B
Total Liabilities 56,81B 47,65B 51,88B 53,01B 54,15B
Shareholders' Equity 53,41B 49,58B 46,74B 43,98B 40,79B
Total Debt 40,86B 32,78B 36,42B 36,07B 36,34B
Cash & Equivalents 9,86B 4,01B 8,08B 8,52B 4,48B
Current Assets 28,71B 22,14B 24,59B 25,23B 20,11B
Current Liabilities 15,19B 13,33B 14,01B 17,01B 13,44B